<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01615861</url>
  </required_header>
  <id_info>
    <org_study_id>714</org_study_id>
    <nct_id>NCT01615861</nct_id>
  </id_info>
  <brief_title>Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens</brief_title>
  <official_title>Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate clinical outcomes following sub-2 mm
      micro-incision cataract surgery (MICS) and intraocular lens (IOL) implantation. This study is
      evaluated in two Phases

        -  V4 (6M) endpoint: primary analysis

        -  V5 (12M) and V6 (34M): EPCO score and Nd Yag incidence analysis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 8, 2012</start_date>
  <completion_date type="Actual">June 16, 2015</completion_date>
  <primary_completion_date type="Actual">June 16, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>6 months</time_frame>
    <description>Corrected distance visual acuity (CDVA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incision size</measure>
    <time_frame>6 Months</time_frame>
    <description>Incision size before and after implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refraction</measure>
    <time_frame>6 Months</time_frame>
    <description>Manifest refraction spherical equivalent. Accuracy to target refraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>6 Months</time_frame>
    <description>Uncorrected distance visual acuity (UDVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EPCO</measure>
    <time_frame>24 Months</time_frame>
    <description>3 mm evaluation of posterior capsule opacification (EPCO) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens decentration</measure>
    <time_frame>6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laser capsulotomy</measure>
    <time_frame>24 Months</time_frame>
    <description>Removal of post-surgical, posterior capsular opacification (PCO)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>IOL implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrophilic acrylic lens implantation through a micro-incision phacoemulsification and cataract surgery (MICS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IOL implantation</intervention_name>
    <description>Micro-incision phacoemulsification cataract surgery (C-MICS) and IOL implantation with 1.8mm cartridge tip insertion technique.</description>
    <arm_group_label>IOL implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL Implantation</intervention_name>
    <description>Micro-incision phacoemulsification cataract surgery (B-MICS) and IOL implantation with 1.4mm wound-assist insertion technique.</description>
    <arm_group_label>IOL implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must have clear intraocular media other than cataract in the study eye.

          -  Subjects must have a clinically documented diagnosis of age-related cataract that is
             considered amenable to treatment with micro-incision phacoemulsification cataract
             extraction in the study eye.

        Exclusion Criteria:

          -  Subjects with ocular malformation in the study eye.

          -  Subjects who have had previous surgery in the study eye.

          -  Subjects with uncontrolled glaucoma in either eye.

          -  Subjects with any anterior segment pathology for which micro-incision
             phacoemulsification cataract surgery would be contraindicated

          -  Subjects using medications known to potentially complicate cataract surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bausch &amp; Lomb</name>
      <address>
        <city>Labege</city>
        <zip>31670</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>May 29, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2012</study_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

